Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Common Stock | Options Exercise | $7M | +68.5K | +63.93% | $102.26 | 176K | Jan 27, 2022 | Direct | |
transaction | CVS | Common Stock | Sale | -$7.36M | -68.5K | -39% | $107.50 | 107K | Jan 27, 2022 | Direct | F1 |
holding | CVS | Common Stock | 34.7K | Jan 27, 2022 | By GRAT | ||||||
holding | CVS | Common Stock (restricted) | 12.8K | Jan 27, 2022 | Direct | ||||||
holding | CVS | ESOP Common Stock | 6.05K | Jan 27, 2022 | By ESOP |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CVS | Stock Option | Options Exercise | $0 | -68.5K | -100% | $0.00* | 0 | Jan 27, 2022 | Common Stock | 68.5K | $102.26 | Direct | F2 |
holding | CVS | Phantom Stock Credits | 1.42K | Jan 27, 2022 | Common Stock | 1.42K | $1.00 | Direct | F3 |
Id | Content |
---|---|
F1 | All sales were effected pursuant to a Rule 10b5-1 plan. |
F2 | Option became exercisable in four equal annual installments, commencing 4/1/2016. |
F3 | Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. |